Results

Total Results: 518 records

Showing results for "renal".

241. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - cardiovascular diseases, cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal … Adverse effects of intervention(s)  All-cause mortality  Cancer and cancer-specific mortality  Renal … upper intake levels (ULs/AEs; specifically, all-cause mortality; cancer and cancer-specific mortality, renal

242. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
     December 29, 2015 - organic anion transporter involved in controlling the reabsorption of uric acid from the proximal renal … Use of lesinurad alone resulted in more patients experiencing elevated serum creatinine levels and renal … , diarrhea, and nausea.27 Some preliminary evidence suggests lesinurad could increase the risk of renal … However, better gout management could reduce hospitalizations and renal or cardiovascular complications … provide cost offsets from treatment with lesinurad.38,40 Two research experts noted concerns over renal

243. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - coronary syndrome o Subpopulations, including: patients with comorbid conditions, such as dementia, or renal … Subgroups of potential interest include: o Patients who have comorbid conditions such as dementia or renal … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … Food and Drug Administration GWTG Get With The Guidelines HAS-BLED hypertension, abnormal renal/liver

244. Disposition of Comments Report for Treatment for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
     November 27, 2012 - treatment-naive individuals and does not consider "difficult-to-treat" populations (e.g., HIV- coinfected, renal … Treatment decisions for HIV-coinfected patients and persons with end- stage renal disease might differ … not aware of trials of antiviral treatments that have specifically enrolled patients with end-stage renal … Additional CERs of treatments in HIV-coinfected patients, patients with end-stage renal disease, and … Additional CERs of treatments in HIV-coinfected patients, patients with end-stage renal disease, and

245. Comparative Effectiveness of Dietary Supplement Versus No Dietary Supplement Use in Adults Taking Cardiovascular Drugs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research-protocol
     December 01, 2019 - Syncope Quality of life Hospitalization Adherence to prescribed cardiovascular drug regimen Renal … aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) Renal … disease, with known cardiovascular disease; participants with diabetes; participants with hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … adverse events, clinical bleeding (intracranial, gastrointestinal, genitourinary, subretinal, etc.), renal

246. Rheumatoid-Arthritis-Medicine Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
     April 01, 2012 - Toxicity was more likely with MTX in patients with greater renal impairment. … Those with high- risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment

247. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
     December 15, 2010 - Syncope • Quality of life • Hospitalization • Adherence to prescribed cardiovascular drug regimen • Renal … aminotransferase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], or hepatitis) o Renal … disease, with known cardiovascular disease; participants with diabetes; participants with hepatic or renal … dysfunction or end-stage renal disease; participants taking a cardiovascular drug for an indication … adverse events, clinical bleeding (intracranial, gastrointestinal, genitourinary, subretinal, etc.), renal

248. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
     December 01, 2023 - by comorbidities (including prepregnancy body mass index, diabetes, hypertension, cardiac disease, renal

249. Dietary-Supplements Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - .); renal dysfunction (e.g., proteinuria, elevated creatinine, need for transplant, glomerular filtration … fatty acids (3 or 6 g/day) + Warfarin Vitamin E (400 IU/day) + ASA Vitamin K (5 mg/day) + Warfarin Renal … bias for the gradable outcomes of harms (serious adverse events, withdrawal due to adverse events, renal … No statistically significant differences were observed for withdrawal due to adverse events,42,73 renal … collect data and undertake subgroup analysis for age, gender, race, comorbidities (e.g., liver or renal

250. Evidence Summary: CER 237_Integrating Palliative Care in Ambulatory Care of Noncancer Serious Chronic Illness (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
     February 01, 2021 - or conditions (e.g., advanced heart failure, chronic obstructive pulmonary disease, or end- stage renal

251. Pain Management Interventions for Elderly Patients With Hip Fracture | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hip-fracture-pain/clinician
     December 01, 2019 - Serious adverse events such as myocardial infarction, stroke, and renal failure were either rarely reported

252. Behavioral Programs for Type 2 Diabetes Mellitus: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-behavior-programs/clinician
     December 01, 2019 - regulation; medication adherence; or self-monitoring for diabetic complications (foot exam, eye exam, and renal

253. Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
     January 01, 2014 - Outcomes varied by study, including plasma substrate level, renal function, cerebrovascular disease … Outcomes varied by study, including plasma substrate level, renal function, cerebrovascular disease … ERT has been shown to stabilize or slow the decline of renal function in patients with Fabry disease … (Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease … Renal or cardiac function outcomes were investigated in six clinical studies of patients with Fabry

254. Comparative Effectiveness of Treatments for Restless Legs Syndrome | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/restless-legs/research-protocol
     December 01, 2019 - to be idiopathic or primary RLS, or secondary to other conditions such as iron deficiency, end-stage renal … characteristics (age, gender, race, comorbidities, disease severity, etiology, iron status, pregnancy, end-stage renal … Studies that include individuals with RLS comorbid with iron deficiency, pregnancy, or end-stage renal

255. Interventions To Decrease Hospital Length of Stay | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/hospital-length-of-stay/report
     March 01, 2022 - low Gillaizeau et al. 2013 Computerized decision support vs. usual care Mix includes diabetes, COPD, renal … low Gillaizeau et al. 2013 Computerized decision support vs. usual care Mix includes diabetes, COPD, renal … low Gillaizeau et al. 2013 Computerized decision support vs. usual care Mix includes diabetes, COPD, renal … low Gillaizeau et al. 2013 Computerized decision support vs. usual care Mix includes diabetes, COPD, renal … low Gillaizeau et al. 2013 Computerized decision support vs. usual care Mix includes diabetes, COPD, renal

256. Diabetes-Drugs-Utilization Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
     March 01, 2011 - of antidiabetic drugs 2 Metformin is also frequently avoided in older adults due to declines in renal … sulfonylurea use in older adults is associated with increased risk of hypoglycemia also due to decreasing renal

257. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/angina-heart-attack-treatments/research-protocol
     December 01, 2019 - percent being cleared by the kidneys, and has a plasma half-life of 25 minutes in patients with normal renal … disease: Subgroups by age, sex, weight, body mass index, diabetes, heart failure, previous stroke, renal … characteristics including age, sex, weight, body mass index, diabetes, heart failure, previous stroke, renal … Analyses by subgroup (e.g., age, sex, weight, body mass index, diabetes, heart failure, previous stroke, renal … minutes and then continued at 0.1 mcg/kg/min for 12 to 24 hr following PCI Patients with severe renal

258. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
     July 01, 2010 - 290.x, 294.1, and 331.2), diabetes mellitus (code 250), hypertension (codes 401-405 and 437.2), and renal … Hypertension — 60 418 (90.6) 6820 (92.7) Peripheral vascular disease — 24 625 (36.9) 3386 (46.0) Renal … 1.35-1.39)b 1.58 (1.52-1.64)b Previous carotid endarterectomy 1.12 (1.05-1.20)c 3.06 (2.65-3.53)b Renal

259. Disposition of Comments CER 214 Stroke Prevention in Patients With Atrial Fibrillation (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
     October 30, 2019 - At least at higher (non-renal) doses the effects look quite similar and I'm not sure it makes sense … Preventing Thromboembolic Events The evidence indicates that the interplay of DOAC dosing and renal … We do however explore patients with renal impairement as a specific subgroup of interest and summarize … to ≤ 95 mL/min, while 30 mg once-daily dose of edoxaban is approved to treat NVAF in patients with renal … At least at higher (non-renal) doses the effectiveness looks quite similar.

260. Behavioral Programs for Type 1 Diabetes Mellitus: Current State of the Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician-2016.pdf
     January 01, 2016 - regulation; medication adherence; or self- monitoring for diabetic complications (foot exam, eye exam, and renal